Advanced search
Publication Cover
Clinical Ophthalmology Volume 9, 2015 - Issue
Submit an article Journal homepage
80
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops

Kenji Inoue1 Inouye Eye Hospital, Tokyo, JapanCorrespondence[email protected]
,
Minako Shiokawa1 Inouye Eye Hospital, Tokyo, Japan
,
Kyoko Ishida2 Department of Ophthalmology, Toho University Ohashi Medical Center, Tokyo, Japan
&
Goji Tomita2 Department of Ophthalmology, Toho University Ohashi Medical Center, Tokyo, Japan
Pages 619-623 | Published online: 09 Apr 2015

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lindsay Machen, Reza Razeghinejad & Jonathan S. Myers. (2020) Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opinion on Pharmacotherapy 21:10, pages 1269-1282.
Read now
Jed Asher Lusthaus & Ivan Goldberg. (2017) Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation. Expert Opinion on Drug Safety 16:9, pages 1071-1078.
Read now

Articles from other publishers (1)

Makoto Aihara, Misato Adachi, Hiroshi Matsuo, Tetsuya Togano, Takeo Fukuchi & Noriyuki Sasaki. (2017) Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients. Acta Ophthalmologica 95:8, pages e720-e726.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.